Print Share

Identifying “longevity genes” in humans

Institution:

Albert Einstein College of Medicine

Researchers:

Nir Barzilai, MD, director of the Institute for Aging Research, director of the Nathan Shock Center of Excellence in the Basic Biology of Aging, professor of medicine and of genetics at Albert Einstein College of Medicine

Impact:

The identification of longevity genes by Einstein researchers may lead to new drug therapies that could slow aging, which would significantly delay the onset of age-related diseases, such as Alzheimer’s disease, type 2 diabetes and cardiovascular disease. This would lead to fewer years of disability and disease and significantly reduce healthcare spending.

Timeline:

2006

Topics

AgingBasic ScienceCancerCardiovascularClinical ResearchDiagnosticsDrug DevelopmentFeaturedGeneticsImmune SystemInfectious DiseaseMedical DeviceMental HealthNeurodegenerativeNobel PrizePediatricsPublic HealthRespiratorySurgical AdvancementTechnologyTreatment AdvancesVaccines

Schools

Albany Medical CollegeAlbert Einstein College of MedicineCity University of New York School of MedicineColumbia University College Of Physicians and SurgeonsHofstra Northwell School of Medicine at Hofstra UniversityIcahn School of Medicine at Mount SinaiJacobs School of Medicine and Biomedical Sciences, the University at BuffaloNew York Institute of Technology College of Osteopathic MedicineNew York Medical CollegeNew York University School of MedicineSchool of Medicine and Dentistry at the University of Rochester Medical CenterStony Brook University School of MedicineSUNY Downstate Medical CenterSUNY Upstate Medical UniversityTouro College of Osteopathic MedicineWeill Cornell MedicineWeill Cornell Medicine, NewYork-Presbyterian